Indivior PLC (LON:INDV - Get Free Report)'s share price was down 15.7% on Thursday . The company traded as low as GBX 548.71 ($6.90) and last traded at GBX 732 ($9.21). Approximately 1,888,371 shares traded hands during mid-day trading, an increase of 166% from the average daily volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.92).
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group reissued a "buy" rating and set a GBX 1,800 ($22.65) target price on shares of Indivior in a research report on Tuesday, December 17th.
Read Our Latest Stock Report on Indivior
Indivior Trading Down 15.7 %
The stock has a market capitalization of £1.14 billion, a PE ratio of -606.93, a PEG ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The business's 50-day moving average is GBX 928.06 and its two-hundred day moving average is GBX 853.71.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
